13.07.2015 Views

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

Guidelines for Complications of Cancer Treatment Vol VIII Part B

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

attributed to use <strong>of</strong> cisplatin based chemotherapy andradiotherapy; and tumor <strong>of</strong> contralateral testis due tounderlying predisposition. In a cohort study by Travis et al.,relative risk <strong>of</strong> SMN was 2.0, 1.8 and 2.9 with RT alone, CTalone and combined CT & RT respectively (11).Breast <strong>Cancer</strong>: Breast cancer patients are at a high risk <strong>of</strong>contralateral breast cancer due to underlying predispositionfactors, radiotherapy associated lung cancer and sarcomas,chemotherapy induced leukemias , tamoxifen inducedendometrial cancers and various genetic cancer syndromes.Risk <strong>of</strong> contralateral breast cancer is two to five folds in patientwith breast cancer but role <strong>of</strong> RT in this risk is not clear. RTon the other hand is clearly linked to lung carcinomas (1.5 to3 times risk), sarcomas and esophageal cancers. With the use<strong>of</strong> IMRT and accelerated partial breast irradiation (APBI),the risk <strong>of</strong> RT associated SMN is likely to decrease (12, 13, 14).Prostate <strong>Cancer</strong>: Patient with prostate cancer are at increasedrisk <strong>of</strong> bladder, colorectal, lung carcinoma and sarcomas. SMNcould be due to radiation carcinogenesis, vigilant screening,incidental finding on investigation done <strong>for</strong> RT complicationsor due to base line high level due to genetic/environmentalfactors. The RR <strong>for</strong> bladder carcinoma after RT <strong>for</strong> carcinomaprostate is variable (between 1-1.5) with a latency period <strong>of</strong>5-10 years. RR <strong>of</strong> bladder cancer is reportedly higher afterpost-prostatectomy RT probably due to irradiation <strong>of</strong> morebladder volume. There is also modest increase in risk <strong>of</strong> rectalcancer after RT with RR varying between 1.2-1.5. Patientstreated with brachytherapy have been reported to have lowerincidence <strong>of</strong> secondary bladder and rectal cancers comparedto external beam RT (1.6 vs. 5.8%; p=0.0623). With theincreasing use <strong>of</strong> IMRT and seed brachytherapy, incidence <strong>of</strong>SMN is again likely to change in course <strong>of</strong> time (15, 16, 17).Cervical <strong>Cancer</strong>: Patients with cervical cancer are at increasedrisk <strong>of</strong> SMN due to shared infectious aetiology (eg. cancer287

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!